A Study Whether Routine Use of Postoperative Belladonna and Opium Suppositories in Vaginal Surgery Improves Pain Control

Overview

About this study

The purpose of this study is to determine whether the routine use of belladonna and opium suppositories will improve pain control following vaginal surgery.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

This study has been completed

Inclusion Criteria

  • Scheduled for elective vaginal surgery requiring general anesthesia at the Mayo Clinic Hospital
    • Would include a vaginal hysterectomy with culdoplasty or post-hysterectomy prolapse repair, including culdoplasty with or without anterior/posterior repair

Exclusion Criteria

  • Participation in another trial using an investigational product
  • Pregnancy
  • Scheduled for a non-vaginal surgical procedure
  • Scheduled for a robotic hysterectomy
  • Scheduled to have combined surgeries (vaginal surgery plus another non-vaginal surgery)
  • A known hypersensitivity to belladonna and/or opium
  • Contraindication to narcotic use
  • Chronic pain with preoperative pain score greater than 4 out of 10 points
  • Clinically significant substance abuse
  • Mental condition that may impair the ability to provide study assessments

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Kristina Butler, M.D., M.S.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20309828

Mayo Clinic Footer